Join
Live feed
·
INSIDERFilingvia Quantisnow
Neurocrine Biosciences Inc. logo

Chief Corp. Affairs Officer Boyer David W. covered exercise/tax liability with 1,936 shares, sold $130,051 worth of shares (826 units at $157.45) as part of a pre-agreed trading plan and was granted 3,587 shares, increasing direct ownership by 10% to 8,722 units (SEC Form 4) (for withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBIX (Neurocrine Biosciences Inc.) and more on Quantisnow.